Full-Time

Veterinary Surgical Specialist

Posted on 10/1/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Columbia, MO, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • BA/BS specializing in a scientific discipline
  • Experience or familiarity with at least one of the following: surgical technique, telemetry, ECG, EEG, or similar procedure in animal species
  • Over 4 years related work experience
  • Basic computer skills including proficiency with Microsoft Office suite; adaptable to new software
  • English proficiency both written and verbal; general reading, writing and verbal communication skills
  • Basic maths skills
  • Work cross functionally on process improvements
  • High level attention to detail
  • Multi-tasking skills and maintain organization in a fast paced, changing environment
  • Effectively manage change
  • Readily adapts to new projects
  • Positive attitude toward work and co-workers
  • Comfortable communicating with all levels of management and employees
  • Identify and resolve problems as they are encountered
  • LATG certification or equivalent preferred
Responsibilities
  • Follow, perform, and develop SOPs and protocols for surgery and surgical support of study and stock animals
  • Manage the daily workflow for the surgical program
  • Coordinate with safety assessment and laboratory animal resources to plan, perform, and create surgical procedures in SOP and protocol form
  • Creation and maintenance of the surgical training program and continued training of personnel to GLP and company standards using written instruction, simulation, practical, and vendor training program resources
  • Ensure continued function and maintenance of surgical equipment
  • Order and inventory supplies in the surgical facilities including study specific supplies
  • Operate selected laboratory equipment (e.g. surgical, imaging, telemetry and ECG equipment)
  • Participate in project and study planning meetings
  • Communicate with clients regarding surgical procedures and facilities
  • Legibly records and reviews raw study and facility data
  • Recognize animal behavior and health status, and reports to appropriate personnel
  • Monitor and report study changes to study director and all appropriate personnel
  • Attend department meetings, reviews, and other pertinent training sessions
  • Maintain and perform general facility cleaning, stocking, and inventory
  • Create, review, and revise SOPs relating to animals, technical procedures, and facility issues
  • Perform and train staff on technical procedures on animals
  • Handle and restrain laboratory animals, including but not limited to, mice, rats, rabbits, canines, and non-human primates
  • Cross-training opportunities available
  • Perform duties of a research specialist or study supervisor
  • Assist with creation of study and staff schedules
Desired Qualifications
  • LATG certification or equivalent preferred
  • Cross-training opportunities available

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech/pharma consolidation demand for single-vendor early-phase development solutions increases.
  • 3D tissue technology adoption reduces animal testing costs and accelerates regulatory approval timelines.
  • Geographic footprint and participant database enable rapid enrollment for mid-size biopharma sponsors.

What critics are saying

  • Novo Holdings divesting Altasciences signals poor financial performance and operational cutbacks.
  • Charles River aggressive pricing on integrated packages captures 20% mid-size biopharma contracts.
  • AI-driven preclinical platforms from Insilico Medicine displace traditional animal safety pharmacology testing.

What makes Altasciences unique

  • Integrated CRO/CDMO spanning preclinical safety testing through Phase IV bioanalysis and manufacturing.
  • 9 North American facilities with 500,000+ participant database conducting 285+ trials annually.
  • VoxCell partnership integrates 3D tissue technology for human-relevant preclinical testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Company News

GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE